Cite
HARVARD Citation
Gallo, S. et al. (2019). Long‐term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104‐week VERTIS MET trial. Diabetes, obesity & metabolism. 21 (4), pp. 1027-1036. [Online].